Literature DB >> 27388241

Bone Regeneration Using the Freshly Isolated Autologous Stromal Vascular Fraction of Adipose Tissue in Combination With Calcium Phosphate Ceramics.

Henk-Jan Prins1, Engelbert A J M Schulten2, Christiaan M Ten Bruggenkate2, Jenneke Klein-Nulend3, Marco N Helder4.   

Abstract

: In patients undergoing maxillary sinus floor elevation (MSFE) for dental implant placement, bone substitutes are currently evaluated as alternatives for autologous bone. However, bone substitutes have only osteoconductive properties and lack osteoinductive potential. Therefore, this phase I study evaluated the potential additive effect on bone regeneration by the addition of freshly isolated, autologous but heterologous stromal vascular fraction (SVF), which is highly enriched with adipose stromal/stem cells when compared with native adipose tissue. From 10 patients, SVF was procured using automatic processing, seeded on either β-tricalcium phosphate (n = 5) or biphasic calcium phosphate carriers (n = 5), and used for MSFE in a one-step surgical procedure. Primary objectives were feasibility and safety. The secondary objective was efficacy, evaluated by using biopsies of the augmented area taken 6 months postoperatively, concomitant with dental implant placement. Biopsies were assessed for bone, graft, and osteoid volumes. No adverse effects were reported during the procedure or follow-up (≥3 years). Bone and osteoid percentages were higher in study biopsies (SVF supplemented) than in control biopsies (ceramic only on contralateral side), in particular in β-tricalcium phosphate-treated patients. Paired analysis on the six bilaterally treated patients revealed markedly higher bone and osteoid volumes using microcomputed tomography or histomorphometric evaluations, demonstrating an additive effect of SVF supplementation, independent of the bone substitute. This study demonstrated for the first time the feasibility, safety, and potential efficacy of SVF seeded on bone substitutes for MSFE, providing the first step toward a novel treatment concept that might offer broad potential for SVF-based regenerative medicine applications. SIGNIFICANCE: This is the first-in-human study using freshly isolated, autologous adipose stem cell preparations (the stromal vascular fraction [SVF] of adipose tissue) applied in a one-step surgical procedure with calcium phosphate ceramics (CaP) to increase maxillary bone height for dental implantations. All 10 patients received CaP plus SVF on one side, whereas bilaterally treated patients (6 of 10) received CaP only on the opposite side. This allowed intrapatient evaluation of the potential added value of SVF supplementation, assessed in biopsies obtained after 6 months. Feasibility, safety, and potential efficacy of SVF for bone regeneration were demonstrated, showing high potential for this novel concept. ©AlphaMed Press.

Entities:  

Keywords:  Adipose stem cells; Bone regeneration; Calcium phosphates; Clinical study; Maxillary sinus floor elevation; Regenerative medicine

Mesh:

Substances:

Year:  2016        PMID: 27388241      PMCID: PMC5031181          DOI: 10.5966/sctm.2015-0369

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  47 in total

1.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Authors:  Marjolijn Duijvestein; Anne Christine W Vos; Helene Roelofs; Manon E Wildenberg; Barbara B Wendrich; Henricus W Verspaget; Engelina M C Kooy-Winkelaar; Frits Koning; Jaap Jan Zwaginga; Herma H Fidder; Auke P Verhaar; Willem E Fibbe; Gijs R van den Brink; Daniel W Hommes
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

2.  Growth factor gene expression profiles of bone morphogenetic protein-2-treated human adipose stem cells seeded on calcium phosphate scaffolds in vitro.

Authors:  J R Overman; M N Helder; C M ten Bruggenkate; E A J M Schulten; J Klein-Nulend; A D Bakker
Journal:  Biochimie       Date:  2013-09-09       Impact factor: 4.079

Review 3.  Stem cells from adipose tissue allow challenging new concepts for regenerative medicine.

Authors:  Marco N Helder; Marlene Knippenberg; Jenneke Klein-Nulend; Paul I J M Wuisman
Journal:  Tissue Eng       Date:  2007-08

4.  Characteristic change and loss of in vivo osteogenic abilities of human bone marrow stromal cells during passage.

Authors:  Hideki Agata; Izumi Asahina; Nobukazu Watanabe; Yumiko Ishii; Noriyuki Kubo; Satoshi Ohshima; Mika Yamazaki; Arinobu Tojo; Hideaki Kagami
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

5.  Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation.

Authors:  S P Bruder; N Jaiswal; S E Haynesworth
Journal:  J Cell Biochem       Date:  1997-02       Impact factor: 4.429

6.  Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.

Authors:  Giovanna Lucchini; Martino Introna; Erica Dander; Attilio Rovelli; Adriana Balduzzi; Sonia Bonanomi; Agnese Salvadè; Chiara Capelli; Daniela Belotti; Giuseppe Gaipa; Paolo Perseghin; Paola Vinci; Edoardo Lanino; Patrizia Chiusolo; Maria Grazia Orofino; Sarah Marktel; Jose Golay; Alessandro Rambaldi; Andrea Biondi; Giovanna D'Amico; Ettore Biagi
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-27       Impact factor: 5.742

7.  Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation.

Authors:  M E Bernardo; L M Ball; A M Cometa; H Roelofs; M Zecca; M A Avanzini; A Bertaina; L Vinti; A Lankester; R Maccario; O Ringden; K Le Blanc; R M Egeler; W E Fibbe; F Locatelli
Journal:  Bone Marrow Transplant       Date:  2010-04-19       Impact factor: 5.483

8.  Adipose stem cells used to reconstruct 13 cases with cranio-maxillofacial hard-tissue defects.

Authors:  George K Sándor; Jura Numminen; Jan Wolff; Tuomo Thesleff; Aimo Miettinen; Veikko J Tuovinen; Bettina Mannerström; Mimmi Patrikoski; Riitta Seppänen; Susanna Miettinen; Markus Rautiainen; Juha Öhman
Journal:  Stem Cells Transl Med       Date:  2014-02-20       Impact factor: 6.940

9.  Long-term in vitro expansion alters the biology of adult mesenchymal stem cells.

Authors:  Reza Izadpanah; Deepak Kaushal; Christopher Kriedt; Fern Tsien; Bindiya Patel; Jason Dufour; Bruce A Bunnell
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).

Authors:  Philippe Bourin; Bruce A Bunnell; Louis Casteilla; Massimo Dominici; Adam J Katz; Keith L March; Heinz Redl; J Peter Rubin; Kotaro Yoshimura; Jeffrey M Gimble
Journal:  Cytotherapy       Date:  2013-04-06       Impact factor: 5.414

View more
  32 in total

Review 1.  Efficacy of autologous stem cells for bone regeneration during endosseous dental implants insertion - A systematic review of human studies.

Authors:  Shailesh Varshney; Anshuman Dwivedi; Vibha Pandey
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-03

2.  Materials-Directed Differentiation of Mesenchymal Stem Cells for Tissue Engineering and Regeneration.

Authors:  J Kent Leach; Jacklyn Whitehead
Journal:  ACS Biomater Sci Eng       Date:  2017-03-14

3.  Blood Vessel Formation and Bone Regeneration Potential of the Stromal Vascular Fraction Seeded on a Calcium Phosphate Scaffold in the Human Maxillary Sinus Floor Elevation Model.

Authors:  Elisabet Farré-Guasch; Nathalie Bravenboer; Marco N Helder; Engelbert A J M Schulten; Christiaan M Ten Bruggenkate; Jenneke Klein-Nulend
Journal:  Materials (Basel)       Date:  2018-01-20       Impact factor: 3.623

Review 4.  Scaffolds for the repair of bone defects in clinical studies: a systematic review.

Authors:  Jian-Hua Zeng; Shi-Wei Liu; Long Xiong; Peng Qiu; Ling-Hua Ding; Shi-Lang Xiong; Jing-Tang Li; Xin-Gen Liao; Zhi-Ming Tang
Journal:  J Orthop Surg Res       Date:  2018-02-12       Impact factor: 2.359

5.  Optimized Bone Regeneration in Calvarial Bone Defect Based on Biodegradation-Tailoring Dual-shell Biphasic Bioactive Ceramic Microspheres.

Authors:  Antian Xu; Chen Zhuang; Shuxin Xu; Fuming He; Lijun Xie; Xianyan Yang; Zhongru Gou
Journal:  Sci Rep       Date:  2018-02-21       Impact factor: 4.379

Review 6.  Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation.

Authors:  Pablo Bora; Anish S Majumdar
Journal:  Stem Cell Res Ther       Date:  2017-06-15       Impact factor: 6.832

7.  Hypothermia reduces VEGF-165 expression, but not osteogenic differentiation of human adipose stem cells under hypoxia.

Authors:  Nick C Leegwater; Astrid D Bakker; Jolanda M A Hogervorst; Peter A Nolte; Jenneke Klein-Nulend
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

Review 8.  Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration.

Authors:  Cyril Bouland; Pierre Philippart; Didier Dequanter; Florent Corrillon; Isabelle Loeb; Dominique Bron; Laurence Lagneaux; Nathalie Meuleman
Journal:  Front Cell Dev Biol       Date:  2021-05-13

9.  Polyphosphate (PolyP) for alveolar cleft repair: study protocol for a pilot randomized controlled trial.

Authors:  S A Alkaabi; D S Natsir Kalla; G A Alsabri; A Fauzi; A Tajrin; W E G Müller; H C Schröder; X G Wang; T Forouzanfar; M N Helder; M Ruslin
Journal:  Trials       Date:  2021-06-14       Impact factor: 2.279

Review 10.  Application of Adipose Tissue Stem Cells in Regenerative Dentistry: A Systematic Review.

Authors:  Sumit Gaur; Rupali Agnihotri
Journal:  J Int Soc Prev Community Dent       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.